Alphatec Holdings, Inc. (ATEC)
About Alphatec Holdings, Inc.
Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others. Its procedural offerings are designed to address the underlying causes of spinal pathology by advancing the three fundamental objectives of spine surgery: (1) decompression of neural elements, (2) stabilization of spinal segments, and (3) restoration and maintenance of proper spinal alignment.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2017
- $101.7M
- Net income
- -$143.4M
- Total assets
- $791.2M
- Market cap
- $1.2B
- Gross margin
- 69.4%
- Operating margin
- -22.3%
- Net margin
- -26.5%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $611.6M
- Cost of revenue
- $187.3M
- Gross profit
- $424.3M
- Operating expenses
- $560.4M
- Operating income
- -$136.2M
- Income tax
- $50.0K
- Net income
- -$162.1M
- EPS (basic)
- $-1.13
- EPS (diluted)
- $-1.13
Balance sheet
- Total assets
- $775.7M
- Current assets
- $417.4M
- Total liabilities
- $789.9M
- Current liabilities
- $153.0M
- Shareholders’ equity
- -$14.2M
Cash flow
- Operating cash flow
- -$44.7M
- Investing cash flow
- -$93.1M
- Financing cash flow
- $56.2M
- Net cash flow
- -$81.6M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $1.2B
- EPS (diluted)
- $-1.13
- Shares outstanding
- 148.9M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jun 2, 2006
Alphatec Holdings, Inc. (ATEC) Stock Price
- Reported a net loss of $143.4M in FY2017.
- Revenue grew 322% from FY2020 to FY2024.
- Gross margin of 69.4%, net margin -26.5%.
- Trading 64% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Alphatec Holdings, Inc..
Write a review
News about Alphatec Holdings, Inc.
News & sentiment via Polygon.io
Alphatec Holdings, Inc.: frequently asked questions
Is Alphatec Holdings, Inc. an American company?
Alphatec Holdings, Inc. is a US-based company headquartered in Carlsbad, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Alphatec Holdings, Inc. headquartered?
Alphatec Holdings, Inc. is headquartered in Carlsbad, California, United States.
Is Alphatec Holdings, Inc. publicly traded?
Yes — Alphatec Holdings, Inc. is a publicly traded company. Its stock trades under the ticker symbol ATEC on the NASDAQ.
What does Alphatec Holdings, Inc. do?
Alphatec Holdings, Inc. is an American Medical Devices company in the Health & Beauty sector.
